Key chemical in dark chocolate may slow down ageing
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Dec-2025 02:11 ET (21-Dec-2025 07:11 GMT/UTC)
Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly accurate diagnostic delivers results to patients in just 15 minutes — up to 75% faster than other rapid HCV tests. This speed is crucial for kickstarting patients’ treatment before they leave their appointment, potentially preventing painful, expensive complications and even death.
The research behind the new test will be published Dec. 10 in The Journal of Infectious Diseases.
HCV can lead to a chronic hepatitis C infection, which affects an estimated 50 million people globally and causes approximately 242,000 deaths annually, largely due to resulting cirrhosis and liver cancer. While the infection is curable with an 8- to 12-week course of medication, treatment rates remain low partially due to lack of affordable and easily accessible diagnostic tests.
Why do some children develop a brain that is too small (microcephaly)? An international research team involving the German Primate Center – Leibniz Institute for Primate Research (DPZ), Hannover Medical School (MHH), and the Max Planck Institute of Molecular Cell Biology and Genetics has used human brain organoids to investigate how changes in important structural proteins in the cell lead to this severe developmental disorder (EMBO Reports).
Researchers compared the genomes of two dangerous bacteria, Escherichia coli (E. coli) and Klebsiella pneumoniae, isolated from blood and faecal samples from Tanzanian newborns admitted with fever. In the majority of cases the bacteria were almost genetically identical, suggesting that the same strain had moved from the gastrointestinal tract into the blood. There was also a bacterial strain that acquired an antimicrobial resistance (AMR) gene between the gut and the blood, a concerning development which limits treatment options.
These findings will support future diagnostic strategies since stool samples are far easier to collect from newborns than blood, allowing clinicians to identify infants at risk of developing sepsis. This development would be vital for very low birthweight babies or those in neonatal units where sepsis and AMR outbreaks can be deadly.